BioNano Genomics Stock News

While virtually every financial advisor will steer you away from these picks, invariably, investors eventually gravitate toward cheap penny stocks to buy. Some might end their fascination with the top

Penny stocks to buy? Short squeeze stocks to watch this week. The post Penny Stocks To Buy Now? 4 Short Squeeze Stocks To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | Pen

Nasdaq bounce off lows is not unusual but momentum indicators suggest a pause for breath

Following brewing clinical momentum, shares of Bionano Genomics (NASDAQ: BNGO ) — a biotechnology firm specializing in nanoscale imaging and analytics — soared on Thursday. This came after the com

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. BioAtla, Inc. (NASDAQ: BCAB) jumped 83.1% to close at $6.61 on Wednesd

BNGO earnings call for the period ending June 30, 2022.

Now's a great time to invest in companies with the potential to grow significantly in the long term.

Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -10% and 7.58%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Bionano Genomics, Inc. (NASDAQ:BNGO ) Q2 2022 Results Conference Call August 4, 2022 4:30 PM ET Company Participants Amy Conrad - Investor Relations Erik Holmlin - Chief Executive Officer Christopher

Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -10% and 7.58%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Bionano Genomics, a pioneer of optical genome mapping solutions, has announced second quarter results that included 73% year-over-year revenue growth as well as a 24% increase in sales of its nanochan

Anika (ANIK) delivered earnings and revenue surprises of 23.08% and 8.95%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SAN DIEGO, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of the first study to evaluate the utility of optical genome mapping (OGM) for myel

SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced that it will host a conference call and live webcast on Thursday, August 4th, 2022 at 4:30 p.m. Eastern Time

Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.